Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

被引：0
|
作者：
Xia Qin
Jian Zhang
Yu Lin
Xue-ming Sun
Jia-ning Zhang
Zhi-qiang Cheng
机构：
[1] Qilu Hospital of Shandong University,Department of General Surgery
[2] The Graduate School of Second Military Medical University,Department of Thoracic Surgery
[3] Shandong Cancer Hospital and Institute,School of Medicine and Life Sciences
[4] Shandong First Medical University and Shandong Academy of Medical Sciences,Department of Neonatology
[5] University of Jinan,The Third Department of Hepatic Surgery
[6] Shandong Academy of Medical Sciences,undefined
[7] The Graduate School of Fujian Medical University,undefined
[8] Yidu Central Hospital of Weifang,undefined
[9] Eastern Hepatobiliary Surgery Hospital,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
MicroRNA-211-5p; ACSL4; Hepatocellular carcinoma; Tumorigenesis; Migration; Invasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma
    Qin, Xia
    Zhang, Jian
    Lin, Yu
    Sun, Xue-ming
    Zhang, Jia-ning
    Cheng, Zhi-qiang
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [2] Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4
    Ma, Lin-Lin
    Liang, Lin
    Zhou, Dan
    Wang, Shao-Wei
    [J]. NEOPLASMA, 2021, 68 (01) : 165 - 173
  • [3] Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2
    Jiang, Guangbin
    Wen, Li
    Deng, Weiping
    Jian, Zhiyuan
    Zheng, Hongmei
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 90 : 806 - 812
  • [4] Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
    Quan, Jing
    Pan, Xiang
    He, Tao
    Lin, Canbin
    Lai, Yulin
    Chen, Peijie
    Zhang, Zeng
    Yang, Shangqi
    Wang, Tao
    Lai, Yongqing
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (04) : 4019 - 4028
  • [5] ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
    Ji Feng
    Pei-zhi Lu
    Guang-zhi Zhu
    Shing Chung Hooi
    Yong Wu
    Xiao-wei Huang
    Hui-qi Dai
    Pan-hong Chen
    Zhong-jie Li
    Wen-jing Su
    Chuang-ye Han
    Xin-ping Ye
    Tao Peng
    Jing Zhou
    Guo-dong Lu
    [J]. Acta Pharmacologica Sinica, 2021, 42 : 160 - 170
  • [6] MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma
    Dang, Shan
    Zhou, Jian
    Wang, Zongyan
    Wang, Kunning
    Dai, Shejiao
    He, Shuixiang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 966 - 975
  • [7] ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
    Feng, Ji
    Lu, Pei-zhi
    Zhu, Guang-zhi
    Hooi, Shing Chung
    Wu, Yong
    Huang, Xiao-wei
    Dai, Hui-qi
    Chen, Pan-hong
    Li, Zhong-jie
    Su, Wen-jing
    Han, Chuang-ye
    Ye, Xin-ping
    Peng, Tao
    Zhou, Jing
    Lu, Guo-dong
    [J]. ACTA PHARMACOLOGICA SINICA, 2021, 42 (01) : 160 - 170
  • [8] ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription
    Wu, Dandan
    Zuo, Zongchao
    Sun, Xinning
    Li, Xin
    Yin, Fangzhou
    Yin, Wu
    [J]. BIOCHEMICAL PHARMACOLOGY, 2024, 224
  • [9] Identification of p115 as a novel ACSL4 interacting protein and its role in regulating ACSL4 degradation
    Sen, Progga
    Kan, Chin Fung Kelvin
    Singh, Amar B.
    Rius, Monica
    Kraemer, Fredric B.
    Sztul, Elizabeth
    Liu, Jingwen
    [J]. JOURNAL OF PROTEOMICS, 2020, 229
  • [10] Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4
    Jiang, Yulang
    Hui, Dengcheng
    Pan, Ziyang
    Yu, Yongxin
    Liu, Lu
    Yu, Xiaofan
    Wu, Chao
    Sun, Mingyu
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (09)
12345